VIGOR Study DesignPopulation

• RA

  • 70% women
  • median age 58 years
  • 56% corticosteroid use

• Important exclusions: low dose ASA use

  Patients deemed by the investigator to require prophylactic ASA or anticoagulation at the time of screening were excluded
  

Previous slide

Next slide

Back to first slide

View graphic version